NBY News and Press, NovaBay Pharmaceuticals Inc. From 06/11/19

CORAL GABLES, FL / ACCESSWIRE / June 11, 2019 / This month the American Society of Clinical Oncology held its annual meeting in Chicago, which brought about more attention to the healthcare sector and biotechstocks . The recent deal between Merck and Tilos Therapeutics has sparked increased...

Gainers:  Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1...

Jaguar Health (NASDAQ: JAGX ) +56%  as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more ... ...

Gainers: NBY   +20.3% . CASY   +9.4% . KEG   +3.5% . CHAP   +3.2% . CXW   +2.7% . More news on: NovaBay Pharmaceuticals, Inc., Casey's General Stores, Inc., Key Energy Services, Inc., Stocks on the move, , News on ETFs Read more ...

NovaBay Pharmaceuticals' (NYSEMKT: NBY ) Avenova Direct is now available at affordable pricing and without a prescription on Amazon.com through the Company’s new direct-to-consumer online channel. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stock...

Original formulation of Avenova ® for the management of bacterial dry eye is now available at an affordable price without a prescription NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for ...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, announces that on May 16, 2019 it received notice (the “Notice”) from the NYSE American LLC that ...

NovaBay Pharmaceuticals, Inc (NBY) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Bruce Voss - Investor Relations, LHA Justin Hall - Interim President & Chief Executive Officer Jason Raleigh - Interim Chief Financial Officer Conference Call P...

NovaBay (NYSEMKT: NBY ): Q1 GAAP EPS of -$0.28 misses by $0.15 . Revenue of $1.5M (-49.2% Y/Y) misses by $0.59M . Shares +10.5% . Press Release More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three mon...